There are a number of factors that are expected to reshape global supply chain processes, but none more than the onset of comparative effectiveness and the need to monitor and document patient outcomes in the United States. This alone will dramatically drive change in the way the entire industry manufactures and distributes…
Wynn Bailey. U.S. Supply Chain Leader, Pharmaceutical and Life Sciences Practice, PwC, a provider of industry-focused assurance, tax and advisory services to build public trust and enhance value for its clients and their stakeholders. For more information, visit pwc.com/us/pharma.
Joseph Bedford, Ph.D. Director of Marketing, Almac Group, a provider of clinical supplies management services, contract manufacturing, and clinical technologies. For more information, visit almacgroup.com.
Domenic Champa. Managing Director, Protiviti Inc., a global consulting firm that helps companies solve problems
in finance, technology, operations, governance, risk and internal audit. For more information, visit protiviti.com.
Dave Shanahan. Global Head of Life Sciences, IDA Ireland, the agency responsible for industrial development in
Ireland. For more information, visit idaireland.com.